Skip to main content

Latest news

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by


Editors' pick

06-14-2017 | Pediatric and adolescent cancers | Conference | News

ASCO 2017

Larotrectinib ‘potential standard of care’ for adult, pediatric TRK fusion tumors

Preliminary findings for larotrectinib suggest that the agent may offer an effective tumor type-agnostic treatment for adults and children presenting with tropomyosin receptor kinase fusions.


J Clin Oncol 2017; 35: LBA2501

Latest headlines

06-26-2017 | Soft-tissue sarcoma | News

ASCO 2017

Aldoxorubicin has activity in advanced soft tissue sarcoma

The doxorubicin conjugate aldoxorubicin could be a suitable alternative to standard therapies for patients with relapsed or refractory soft tissue sarcoma, say researchers.


J Clin Oncol 2017; 35: 11000

06-23-2017 | Breast cancer | News

Adjuvant capecitabine improves prognosis in high-risk breast cancer

Patients with residual invasive disease after standard neoadjuvant chemotherapy for HER2-negative breast cancer benefit from adjuvant treatment with capecitabine, CREATE-X trial data show.


N Engl J Med 2017; 376: 2147–2159

06-23-2017 | Prostate cancer | News

PAM50 classifier defines prostate cancer subtypes

Patients with prostate cancer can be classified into luminal- and basal-like subtypes using the well-known PAM50 algorithm, and the subtypes correlate with clinical outcome, researchers report.


JAMA Oncol 2017; Advance online publication

06-22-2017 | Chronic myeloid leukemia | Conference | News

ASCO 2017

Frontline bosutinib ‘an option’ for newly diagnosed CP CML

Study findings suggest that bosutinib could be considered as an alternative to imatinib for first-line tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase.


J Clin Oncol 2017; 35: 7002

In depth

04-21-2017 | Lymphoma | Feature | Article

Lymphoma in practice: Professor Anas Younes speaks to medwireNews

Professor Anas Younes tells medwireNews about the current issues in lymphoma practice, both for the clinician and patients.

02-01-2017 | Patient-reported outcomes | Feature | Article

The time is right for patient-reported outcomes

medwireNews talks to Professor Dame Lesley Fallowfield and Dr Ethan Basch about the barriers to the routine incorporation of patient-reported outcomes in oncology clinical trials, and the changes that are happening.

Ask the expert

Are you a healthcare professional with questions about the management of oncology patients? Submit a question here and we'll put a selection of the best to our advisory board.

Calendar Upcoming events

Conference highlights

06-04-2017 | Collection

medwireNews@ASCO 2017

We provide coverage from the annual meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, USA. Click through for news stories, conference reports, interviews and more.

02-03-2017 | Collection

ASH 2016

News from annual meeting of the American Society of Hematology, held in San Diego, California, USA. Click through to read the full reports.

02-01-2017 | Collection

ESMO 2016

News and conference reports from the ESMO 2016 Congress, held in Copenhagen, Denmark. Click through to read the full reports of the latest research.

Latest from us on Twitter

Updates from oncology organizations

image credits